If ignored, this tingling can progress into numbness, balance issues, and coordination problems
Analysis of the available research reports that tirzepatide administered at 15mg/weekly may result in a hazard ratio (HR) of 0.8 for the incidence of cardiovascular events
By the numbers: According to the Centers for Disease Control and Prevention, more than 100 million adults in the U.S
Source: Arrone, et al New England J of Medicine May 11, 2025 Implications for employers: Employers looking to cover GLP-1 medications for weight loss should review formulary options to best balance cost and clinical outcomes
Studies have shown that it can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss
I love coming here and feel amazing when I leave